[
  {
    "ts": null,
    "headline": "GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm",
    "summary": "GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.",
    "url": "https://finnhub.io/api/news?id=4e020f064b6d7eaa7ff11651d630b7a179955161306ebb1ac3ba900ca13bcee7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743528180,
      "headline": "GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm",
      "id": 133658277,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.",
      "url": "https://finnhub.io/api/news?id=4e020f064b6d7eaa7ff11651d630b7a179955161306ebb1ac3ba900ca13bcee7"
    }
  },
  {
    "ts": null,
    "headline": "FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout",
    "summary": "The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.",
    "url": "https://finnhub.io/api/news?id=97882ec59f886dd92856d986867aa4d9f9bd733ce831c4e4bc3eae6459a9bd38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743527130,
      "headline": "FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout",
      "id": 133655198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.",
      "url": "https://finnhub.io/api/news?id=97882ec59f886dd92856d986867aa4d9f9bd733ce831c4e4bc3eae6459a9bd38"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech",
    "summary": "GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.",
    "url": "https://finnhub.io/api/news?id=77490cd25aa0ae70396b1f0da537215cdbca0dc51a12e0e8f24dc539fa4862cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743525660,
      "headline": "GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech",
      "id": 133655236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.",
      "url": "https://finnhub.io/api/news?id=77490cd25aa0ae70396b1f0da537215cdbca0dc51a12e0e8f24dc539fa4862cb"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires",
    "summary": "We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and […]",
    "url": "https://finnhub.io/api/news?id=4dd5a066c020f1e0ac5115bd093348df32d042f2a2f0b41879d8319226cc2ad2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743515729,
      "headline": "Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires",
      "id": 133645393,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and […]",
      "url": "https://finnhub.io/api/news?id=4dd5a066c020f1e0ac5115bd093348df32d042f2a2f0b41879d8319226cc2ad2"
    }
  },
  {
    "ts": null,
    "headline": "ABT Stock to Gain From Early CE Mark Approval of Volt PFA System",
    "summary": "Abbott achieves early CE Mark approval for the Volt PFA system.",
    "url": "https://finnhub.io/api/news?id=f41ad3db092f673878e5a694e0a7cae46e2eee20da70fb06e53eb42b361409f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743510420,
      "headline": "ABT Stock to Gain From Early CE Mark Approval of Volt PFA System",
      "id": 133645299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Abbott achieves early CE Mark approval for the Volt PFA system.",
      "url": "https://finnhub.io/api/news?id=f41ad3db092f673878e5a694e0a7cae46e2eee20da70fb06e53eb42b361409f8"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces conference call discussing first quarter 2025 results",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 23 prior to the conference call.",
    "url": "https://finnhub.io/api/news?id=cfa54c2e1d7c293963469ae6e83249811529fc9288ba422f6842ff0c0f6e9236",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743508800,
      "headline": "Boston Scientific announces conference call discussing first quarter 2025 results",
      "id": 133645396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 23 prior to the conference call.",
      "url": "https://finnhub.io/api/news?id=cfa54c2e1d7c293963469ae6e83249811529fc9288ba422f6842ff0c0f6e9236"
    }
  },
  {
    "ts": null,
    "headline": "ABT Stock Gains Following the Positive TRILUMINATE Trial Results",
    "summary": "Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.",
    "url": "https://finnhub.io/api/news?id=46c17aadac175ed3afd815f08a303c1fc8358d4f284d9a308bacee91211293e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743506520,
      "headline": "ABT Stock Gains Following the Positive TRILUMINATE Trial Results",
      "id": 133645301,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.",
      "url": "https://finnhub.io/api/news?id=46c17aadac175ed3afd815f08a303c1fc8358d4f284d9a308bacee91211293e1"
    }
  },
  {
    "ts": null,
    "headline": "Impax Global Social Leaders Fund Q4 2024 Commentary",
    "summary": "Impax Global Social Leaders Fund underperformed the benchmark during the quarter. Positive performance came from Industrials. Read more here.",
    "url": "https://finnhub.io/api/news?id=d71e06b3d4b48830fe0c9b083cefccd7490e3cd16ef30c9a69398f98c79e4262",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743474420,
      "headline": "Impax Global Social Leaders Fund Q4 2024 Commentary",
      "id": 133632038,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/173236543/image_173236543.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Impax Global Social Leaders Fund underperformed the benchmark during the quarter. Positive performance came from Industrials. Read more here.",
      "url": "https://finnhub.io/api/news?id=d71e06b3d4b48830fe0c9b083cefccd7490e3cd16ef30c9a69398f98c79e4262"
    }
  },
  {
    "ts": null,
    "headline": "Impax Global Opportunities Fund Q4 2024 Commentary",
    "summary": "Impax Global Opportunities Fund underperformed the benchmark during the last quarter. Its overweight position in Health Care was a relative headwind. Read more here.",
    "url": "https://finnhub.io/api/news?id=c0178616e50528f111610f72c959c742270fa344c71e1e87d7a42d41553701b0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743469380,
      "headline": "Impax Global Opportunities Fund Q4 2024 Commentary",
      "id": 133631570,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/912015114/image_912015114.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Impax Global Opportunities Fund underperformed the benchmark during the last quarter. Its overweight position in Health Care was a relative headwind. Read more here.",
      "url": "https://finnhub.io/api/news?id=c0178616e50528f111610f72c959c742270fa344c71e1e87d7a42d41553701b0"
    }
  }
]